SCHEMBL4967987

SCHEMBL4967987

O=C(O)c1c[nH]c(=O)c(C2CCC(c3ccccc3)C2)c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.44
AKR1C1 Q04828 1/20 0.44
TRPV6 Q9H1D0 1/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.41
KMT2A Q03164 1/20 0.41
RARG P13631 2/20 0.40
RARB P10826 1/20 0.40
KMO O15229 1/20 0.38
LIPG Q9Y5X9 2/20 0.38
TNKS O95271 3/20 0.37
P2RY14 Q15391 1/20 0.37
NOTUM Q6P988 1/20 0.36
SLC18A3 Q16572 1/20 0.36
SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4965859 0.95 KMO (0.43) AKR1C3AKR1C1TRPV6ALDH1A1KDM4E
SCHEMBL6209027 0.84 NOTUM (0.46) ALDH1A1KDM4EMEN1GAAKMT2A
SCHEMBL4969223 0.78 NOTUM (0.43) KMONOTUM
SCHEMBL4966863 0.77 RAB9A (0.45) KDM4EMEN1KMT2AKMONOTUM
SCHEMBL4969319 0.76 NOTUM (0.39) ALDH1A1MEN1KMT2ARARGRARB
Bicarbonate SCHEMBL7572186 0.72 AKR1C3 (0.70) AKR1C3AKR1C1ALDH1A1GAALIPG
SCHEMBL31702895 0.70 CDC7 (0.38) KDM4EMEN1KMT2ATNKS
Benzoic Acid SCHEMBL11807312 0.69 TSHR (0.56) AKR1C3AKR1C1ALDH1A1RARGRARB
SCHEMBL9472162 0.69 TSHR (0.52) AKR1C3AKR1C1ALDH1A1RARGRARB
SCHEMBL10895189 0.68 AKR1C3 (0.61) AKR1C3AKR1C1GAASLC18A3SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1954693-A1 BETA-SECRETASE MODULATORS AND METHODS OF USE Amgen Inc. (US) 2008-08-13 EP disclosed
WO-2007062007-A1 BETA-SECRETASE MODULATORS AND METHODS OF USE AMGEN INC. (US) 2007-05-31 WO disclosed